- Home
- FRST vs FHTX Comparison
FRST vs FHTX Comparison
Compare FRST & FHTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | FRST | FHTX |
|---|---|---|
| Founded | 2004 | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Medicinal Chemicals and Botanical Products |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 261.7M | 247.1M |
| IPO Year | 2006 | 2020 |
Fundamental Metrics
Financial Performance| Metric | FRST | FHTX |
|---|---|---|
| Price | $13.40 | $4.37 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 7 |
| Target Price | N/A | ★ $11.86 |
| AVG Volume (30 Days) | 86.1K | ★ 185.9K |
| Earning Date | 01-27-2026 | 11-05-2025 |
| Dividend Yield | ★ 2.99% | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ 0.34 | N/A |
| Revenue | ★ $138,816,000.00 | $24,518,000.00 |
| Revenue This Year | $13.75 | $47.50 |
| Revenue Next Year | $35.05 | N/A |
| P/E Ratio | $39.35 | ★ N/A |
| Revenue Growth | ★ 33.08 | N/A |
| 52 Week Low | $7.59 | $2.95 |
| 52 Week High | $13.46 | $6.79 |
Technical Indicators
Market Signals| Indicator | FRST | FHTX |
|---|---|---|
| Relative Strength Index (RSI) | 80.14 | 47.41 |
| Support Level | $11.01 | $4.33 |
| Resistance Level | $12.47 | $4.59 |
| Average True Range (ATR) | 0.34 | 0.25 |
| MACD | 0.21 | -0.02 |
| Stochastic Oscillator | 95.44 | 20.00 |
Price Performance
Historical ComparisonAbout FRST Primis Financial Corp.
Primis Financial Corp is the bank holding company for Primis Bank, providing financial services to individuals and small and medium-sized businesses. Primis Bank offers a wide range of commercial banking services, It focuses on making loans secured mainly by commercial real estate and other types of secured and unsecured commercial loans to small and medium-sized businesses in several industries, as well as loans to individuals for a variety of purposes. Primis Bank offers a broad range of deposit products, including checking (NOW), savings, money market accounts, and certificates of deposit. Its operating segments are Primis Mortgage, Primis Bank, and Other.
About FHTX Foghorn Therapeutics Inc.
Foghorn Therapeutics Inc is engaged in the discovery and development of a new class of medicines targeting genetically determined dependencies within the chromatin regulatory system. Its proprietary Gene Traffic Control platform gives an integrated, mechanistic understanding of how the various components of the chromatin regulatory system interact, allowing it to identify, validate, and potentially drug targets within the system. The company is developing FHD-286, a selective, allosteric ATPase inhibitor, and FHD-609, a protein degrader, to treat hematologic cancers and solid tumors.